Furthermore, insomnia in the context of OSA has been associated with distinct neurotrophin profiles, suggesting a unique neurobiological substrate that may influence treatment responses and outcomes [46,47,48], while chronotype has been shown to be associated with insomnia symptoms among OSA individuals [49]. This evidence concerns the gene BDNF and insomnia measurement.